---
title: "VICO: Buloxibutid shows strong efficacy and safety for IPF, advancing in a pivotal global Phase 2b trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296869802.md"
description: "Focused on developing buloxibutid, an oral AT2 receptor agonist, for IPF, the company has shown promising efficacy and safety in clinical trials, with a robust mechanism targeting tissue repair and fibrosis. Positioned for global leadership, it is well-funded, has a major partnership in Japan, and is advancing through a pivotal Phase 2b trial.Original document: Vicore Pharma Holding AB [VICO] Slides Release — Aug. 25 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-25T06:44:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296869802.md)
  - [en](https://longbridge.com/en/news/296869802.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296869802.md)
generator: "portal-rs"
---

# VICO: Buloxibutid shows strong efficacy and safety for IPF, advancing in a pivotal global Phase 2b trial

Focused on developing buloxibutid, an oral AT2 receptor agonist, for IPF, the company has shown promising efficacy and safety in clinical trials, with a robust mechanism targeting tissue repair and fibrosis. Positioned for global leadership, it is well-funded, has a major partnership in Japan, and is advancing through a pivotal Phase 2b trial.

Original document: Vicore Pharma Holding AB \[VICO\] Slides Release — Aug. 25 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [VCRE.US](https://longbridge.com/en/quote/VCRE.US.md)

## Related News & Research

- [MAZE: Promising phase II results in AMKD and PKU, with pivotal trials and key data readouts ahead](https://longbridge.com/en/news/298476154.md)
- [Asana (ASAN) Is Down 13.5% After AI-Driven Margin Pressure Narrows Outlook - Has The Bull Case Changed?](https://longbridge.com/en/news/298153052.md)
- [Sony Semiconductor Solutions signs non-binding MoU with Aramco on industrial AI collaboration](https://longbridge.com/en/news/298168154.md)
- [CISO: A New Front Line Star in the AI Cybersecurity War](https://longbridge.com/en/news/298152955.md)
- [Optical Cable GAAP EPS of $0.21, revenue of $24.3M](https://longbridge.com/en/news/298459179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**